Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Grinyo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|August 18, 2016
Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol BiopsiesFernanda Ortiz, Rosana Gelpi, Ilkka Helanterä, et al.
Transplantation|December 16, 2010
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipientsJohn M Kovarik, Jürg U Steiger, Josep M Grinyo, et al.
Transplantation|April 23, 2009
Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony StudyFederico Oppenheimer, Pablo Rebollo, Josep M Grinyo, et al.
Cell Transplantation|February 5, 2017
The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal AllotransplantationAna Merino, Elia Ripoll, Laura de Ramon, et al.
The American Journal of Pathology|January 1, 2003
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?Immaculada Herrero-Fresneda, Joan Torras, Josep M Cruzado, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 20, 2015
De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoringEdoardo Melilli, Elena Crespo, Diego Sandoval, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 21, 2013
The effect of rabbit antithymocyte globulin on human mesenchymal stem cellsMarcella Franquesa, Carla C Baan, Sander S Korevaar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trialYves Vanrenterghem, Johannes P van Hooff, Jean-Paul Squifflet, et al.
Kidney Medicine|January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialObbo W Bredewold, Joe Chan, My Svensson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|August 18, 2016
Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol BiopsiesFernanda Ortiz, Rosana Gelpi, Ilkka Helanterä, et al.
Transplantation|December 16, 2010
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipientsJohn M Kovarik, Jürg U Steiger, Josep M Grinyo, et al.
Transplantation|April 23, 2009
Health-related quality of life of patients receiving low-toxicity immunosuppressive regimens: a substudy of the Symphony StudyFederico Oppenheimer, Pablo Rebollo, Josep M Grinyo, et al.
Cell Transplantation|February 5, 2017
The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal AllotransplantationAna Merino, Elia Ripoll, Laura de Ramon, et al.
The American Journal of Pathology|January 1, 2003
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?Immaculada Herrero-Fresneda, Joan Torras, Josep M Cruzado, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 20, 2015
De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoringEdoardo Melilli, Elena Crespo, Diego Sandoval, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 21, 2013
The effect of rabbit antithymocyte globulin on human mesenchymal stem cellsMarcella Franquesa, Carla C Baan, Sander S Korevaar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trialYves Vanrenterghem, Johannes P van Hooff, Jean-Paul Squifflet, et al.
Kidney Medicine|January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialObbo W Bredewold, Joe Chan, My Svensson, et al.
Pageof 2